Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2020 | Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemness | Chang, YC; Yang, YF; Chiou, J; Tsai, HF; Fang, CY; Yang, CJ; Chen, CL; Hsiao, M | Cell Death & Disease 11(3), 195 | | | |
2022 | Novel Monodisperse FePt Nanocomposites for T2-weighted Magnetic Resonance Imaging: Biomedical Theranostics Applications | Chang, ZX; Li, CH; Chang, YC; Huang, CYF; Chan, MH; Hsiao, M | NANOSCALE ADVANCES 4(2), 377-386 | | | |
2020 | Omics-based Platforms: Current Status and Potential Use for Cholangiocarcinoma | Chang, YC; Chen, MH; Yeh, CN; Hsiao, M | Biomolecules 10(10), 1377 | | | |
2021 | OncomiR miR-182-5p Enhances Radiosensitivity by Inhibiting the Radiation-Induced Antioxidant Effect through SESN2 in Head and Neck Cancer | Lin, MY; Chang, YC; Wang, SY; Yang, MH; Chang, CH; Hsiao, M ; Kitsis, RN; Lee, YJ | ANTIOXIDANTS 10(11), 1808 | | | |
2022 | Oral Cancer Theranostic Application of FeAu Bimetallic Nanoparticles Conjugated with MMP-1 Antibody | Tsai, MT; Sun, YS; Keerthi, M; Panda, AK; Dhawan, U; Chang, YH; Lai, CF; Hsiao, M ; Wang, HY; Chung, RJ | NANOMATERIALS 12(1), 61 | | | |
2019 | Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of the glioblastoma cells, as well as potentiate the anticancer effect of temozolomide | Su, YK; Bamodu, OA; Tzeng, YM; Hsiao, M ; Lin, CM; Yeh, CT | Phytomedicine 61, 152840 | | | |
2019 | Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts | Chen, JH; Wu, ATH; Bamodu, OA; Yadav, VK; Chao, TY; Tzeng, YM; Mukhopadhyay, D; Hsiao, M ; Lee, JC | Cancers 12(1), 56 | | | |
2020 | Ovatodiolide, isolated from Anisomeles indica, suppresses bladder carcinogenesis through suppression of mTOR/β-catenin/CDK6 and exosomal miR-21 derived from M2 tumor-associated macrophages | Wu, ATH; Srivastava, P; Yadav, Vijesh K; Tzeng, DTW; Iamsaard, S; Su, ECY; Hsiao, M ; Liu, MC | Toxicology and Applied Pharmacology 401, 115109 | | | |
2019 | Over-expression of TNNI3K is associated with early-stage carcinogenesis of cholangiocarcinom | Yeh, CN; Chen, MH; Chang, YC; Wu, RC; Tsao, LC; Wang, SY; Cheng, CT; Chiang, KC; Chen, TW; Hsiao, M ; Weng, WH | Molecular Carcinogenesis 58(2), 270-278 | | | |
2019 | Overexpression of BZW1 is an independent poor prognosis marker and its down-regulation suppresses lung adenocarcinoma metastasis | Chiou, J; Chang, YC; Jan, YH; Tsai, HF; Yang, CJ; Huang, MS; Yu, YL; Hsiao, M | Scientific Reports 9, 14624 | | | |
2020 | Overexpression of PSAT1 promotes metastasis of lung adenocarcinoma by suppressing the IRF1-IFNγ axis | Chan, YC; Chang, YC; Chuang, HH; Yang, YC; Lin, YF; Huang, MS; Hsiao, M ; Yang, CJ; Hua, KT | Oncogene 39(12), 2509-2522 | | | |
2023 | Overexpression of Synaptic Vesicle Protein Rab GTPase 3C Promotes Vesicular Exocytosis and Drug Resistance in Colorectal Cancer Cells | Chang, Yu‐Chan; Li, Chien‐Hsiu; Chan, Ming‐Hsien; Fang, Chih‐Yeu; Zhang, Zhi‐Xuan; Chen, Chi‐Long; Hsiao, Michael | MOLECULAR ONCOLOGY 17(3), 422-444 | | | |
2022 | PCK1 Regulates Neuroendocrine Differentiation in A Positive Feedback Loop of LIF/ZBTB46 Signalling in Castration-resistant Prostate Cancer | Wen, YC; Liu, CL; Yeh, HL; Chen, WH; Jiang, KC; Tram, VT; Hsiao, M ; Huang, J; Chen, WY; Liu, YN | BRITISH JOURNAL OF CANCER 126, 778-790 | | | |
2021 | PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway | Pai, S; Yadav, VK; Kuo, KT; Pikatan, NW; Lin, CS; Chien, MH; Lee, WH; Hsiao, M ; Chiu, SC; Yeh, CT; Tsai, JT | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22(21), 11492 | | | |
2020 | Pin1 coordinates HDAC6 upregulation with cell migration in lung cancer cells | Chuang, HH; Hsu, JF; Chang, HL; Wang, PH; Wei, PJ; Wu, DW; Huang, MS; Hsiao, M ; Yang, CJ | International Journal of Medical Sciences 17(17), 2635-2643 | | | |
2020 | PRKDC: A New Biomarker and drug target for Checkpoint Blockade Immunotherapy | Tan, KT; Yeh, CN; Chang, YC; Cheng, JH; Fang, WL; Yeh, YC; Hsu, DS; Wu, CE; Liu, CY; Chang, MS; Lu, ML; Chen, SJ; Yee, C; Hsiao, M ; Chen, MH | Journal for ImmunoTherapy of Cancer 8(1), e000485 | | | |
2022 | Progress and Viewpoints of Multifunctional Composite Nanomaterials for Glioblastoma Theranostics | Chan, MH; Huang, WT; Satpathy, A; Su, TY; Hsiao, M ; Liu, RS | PHARMACEUTICS 14(2), 456 | | | |
2017 | Protease-activated nanomaterials for targeted cancer theranostics | Chan, YC; Hsiao, M | Nanomedicine 12(18), 2153-2159 | | | |
2023 | Proteoglycan SPOCK1 as a Poor Prognostic Marker Promotes Malignant Progression of Clear Cell Renal Cell Carcinoma via Triggering the Snail/Slug-MMP-2 Axis-Mediated Epithelial-to-Mesenchymal Transition | Lin, Yung-Wei; Wen, Yu-Ching; Hsiao, Chi-Hao; Lai, Feng-Ru; Yang, Shun-Fa; Yang, Yi-Chieh; Ho, Kuo-Hao; Hsieh, Feng-Koo; Hsiao, Michael ; Lee, Wei-Jiunn; Chien, Ming-Hsien | CELLS 12(3), 352 | | | |
2021 | Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma | Yang, YC; Chien, MH; Lai, TC; Tung, MC; Jan, YH; Chang, WM; Jung, SM; Chen, MH; Yeh, CN; Hsiao, M | JOURNAL OF BIOMEDICAL SCIENCE 28, 29 | | | |